© 1997 by European Society of Cardiology
Copyright © 1997, European Society of Cardiology
Increased cardiac expression of endothelin-1 mRNA in ischemic heart failure in rats
aInstitute for Experimental Medical Research, Ullevål Hospital, Oslo, Norway
bResearch Forum, Ullevål Hospital, Oslo, Norway
cInstitute for Surgical Research, The National Hospital, Oslo, Norway
Objectives: Plasma endothelin (ET) concentrations are increased in heart failure. The aims of the present study were to investigate to what extent cardiac ET mRNA expression is induced in ischemic heart failure and whether there may be compensatory downregulation of myocardial mRNA levels for the ETA and ETB receptor subtypes. Methods: In rats with ischemic heart failure (left ventricular end-diastolic pressure > 15 mmHg) due to left coronary artery ligation, Northern blot analyses were performed on mRNA isolated from cardiac tissues. Results: A substantial upregulation was revealed in all chambers of the failing hearts. Up to 27-fold upregulation (mean 10.6 ± 4.0, P = 0.002) of left ventricular ET-1 mRNA levels was measured 1 week after myocardial infarction, whereas only a modest upregulation was detected after 6 weeks (mean 2.7 ± 0.5, P < 0.05). Ribonuclease protection assay revealed 2.8 ± 0.4-fold higher levels of ET-1 mRNA in the left ventricular area subjected to myocardial infarction compared to the non-infarcted tissue after 1 week. Left ventricular ET-1 mRNA correlated significantly with left ventricular end-diastolic pressure after 1 week (r2 = 0.86, P = 0.007). The ETA and ETB receptor mRNA levels tended to increase 1 week after myocardial infarction although these changes were not statistically significant. Conclusions: Cardiac ET-1 mRNA levels are increased in ischemic heart failure and correlate significantly with left ventricular end-diastolic pressure 1 week after myocardial infarction. The increase in cardiac ET-1 mRNA is not accompanied by a decrease in ET receptor mRNA.
KEYWORDS Endothelin; Heart failure; mRNA; Rat
* Corresponding author. Institute for Experimental Medical Research, Ullevål Hospital, Kirkeveien 166, 0407 Oslo, Norway. Tel. +47 22 600390; Fax +47 22 600393.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  N. Isidoro Tavares, P. Philip-Couderc, A. J. Baertschi, R. Lerch, and C. Montessuit Angiotensin II and tumour necrosis factor {alpha} as mediators of ATP-dependent potassium channel remodelling in post-infarction heart failure Cardiovasc Res, September 1, 2009; 83(4): 726 - 736. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-J. Li, C.-X. Huang, C.-H. Fang, Fang Chen, Hong Jiang, Q.-Z. Tang, and G.-S. Li Circadian Variation in Ischemic Threshold in Patients with Stable Angina: Relation to Plasma Endothelin-1 Angiology, July 1, 2002; 53(4): 409 - 413. [Abstract] [PDF]
|
|
|
|
 |
|
 P. K. Lunde, E. Verburg, M. Eriksen, and O. M Sejersted Contractile properties of in situ perfused skeletal muscles from rats with congestive heart failure J. Physiol., April 15, 2002; 540(2): 571 - 580. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. B Sande, I. Sjaastad, I. B Hoen, J. Bokenes, T. Tonnessen, E. Holt, P. K Lunde, and G. Christensen Reduced level of serine16 phosphorylated phospholamban in the failing rat myocardium: a major contributor to reduced SERCA2 activity Cardiovasc Res, February 1, 2002; 53(2): 382 - 391. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Tonnessen, P. Kristian Lunde, A. Giaid, O. M Sejersted, and G. Christensen Pulmonary and cardiac expression of preproendothelin-1 mRNA are increased in heart failure after myocardial infarction in rats. Localization of preproendothelin-1 mRNA and endothelin peptide Cardiovasc Res, September 1, 1998; 39(3): 633 - 643. [Abstract] [Full Text] [PDF]
|
|